+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Epilepsy Therapeutic Market in APAC 2024-2028 - Product Thumbnail Image

Epilepsy Therapeutic Market in APAC 2024-2028

  • Report
  • January 2024
  • 156 Pages
  • Asia Pacific
From
From
Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2025 - Product Thumbnail Image

Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
From
From
From
From
Glycan Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Glycan Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Voltage-Dependent Calcium Channel Blockers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Tau Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Tau Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Amyloid Beta-protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Amyloid Beta-protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator